Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...
Nerve-stimulation therapy can greatly improve symptoms of severe, treatment-resistant depression, a new clinical trial shows. The results of the trial, published last month in a pair of studies in ...
The trial, part of which is still underway, was intended to evaluate the effectiveness of nerve-stimulation therapy for severe depression, both alone and as part of bipolar disorder. Men’s ...